Exchange: NASDAQ·Updated 03:57 PM EDT
GLTO logo

GLTO Galecto Inc

$32.46
$0.66
(2.08%)
Today
Reported EarningsMay 12
Mkt Cap$1.96B
Vol16,969.00

About GLTO

Damora Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Waltham, MA.
55

Bullish Sentiment

How do you feel about GLTO?

Advertisement|Remove ads.